Eye Drop in Clinical Testing for Treatment of Wet-AMD
Continue ReadingTag: lucentis
Vista Partners Updates Coverage on Ohr Pharmaceutical, Inc.; Target Price $3.50
SAN FRANCISCO, CA -- (Marketwire) -- 10/17/12 -- announced today that it has updated coverage on…
Continue Reading